Download Free Sample Report

Cognition-Enhancing Drugs Market - Global Outlook and Forecast 2022-2028

Cognition-Enhancing Drugs Market - Global Outlook and Forecast 2022-2028

  • Published on : 21 July 2022
  • Pages :79
  • Report Code:SMR-7218816

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
This report contains market size and forecasts of Cognition-Enhancing Drugs in global, including the following market information:
Global Cognition-Enhancing Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cognition-Enhancing Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Cognition-Enhancing Drugs companies in 2021 (%)
The global Cognition-Enhancing Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cognition-Enhancing Drugs include Accelerated Intelligence, Cognition Therapeutics, Cogstate, HVMN and Biogen Idec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cognition-Enhancing Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cognition-Enhancing Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Cognition-Enhancing Drugs Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Cognition-Enhancing Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Cognition-Enhancing Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Global Cognition-Enhancing Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Cognition-Enhancing Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cognition-Enhancing Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cognition-Enhancing Drugs revenues share in global market, 2021 (%)
Key companies Cognition-Enhancing Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Cognition-Enhancing Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec